IRulya Therapeutics, Inc. (IRLA)
39.93
-0.01
(-0.03%)
USD |
NASDAQ |
Nov 20, 16:00
39.93
0.00 (0.00%)
After-Hours: 20:00
IRulya Therapeutics Gross Profit (TTM) : -0.131M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.131M |
| June 30, 2026 | -0.152M |
| March 31, 2026 | -0.146M |
| December 31, 2025 | -0.142M |
| September 30, 2025 | -0.119M |
| June 30, 2025 | -0.169M |
| March 31, 2025 | -0.178M |
| December 31, 2024 | -0.186M |
| September 30, 2024 | -0.474M |
| June 30, 2024 | -0.388M |
| March 31, 2024 | -0.345M |
| December 31, 2023 | -0.322M |
| September 30, 2023 | -0.06M |
| June 30, 2023 | -0.10M |
| March 31, 2023 | -0.183M |
| December 31, 2022 | -0.204M |
| September 30, 2022 | -0.246M |
| Date | Value |
|---|---|
| June 30, 2022 | -0.293M |
| March 31, 2022 | -0.296M |
| December 31, 2021 | -0.344M |
| September 30, 2021 | -0.345M |
| June 30, 2021 | -0.342M |
| March 31, 2021 | -0.335M |
| December 31, 2020 | -0.332M |
| September 30, 2020 | -0.323M |
| June 30, 2020 | -0.298M |
| March 31, 2020 | -0.252M |
| December 31, 2019 | -0.188M |
| September 30, 2019 | -0.121M |
| June 30, 2019 | -0.07M |
| March 31, 2019 | -0.036M |
| June 30, 2018 | -0.017M |
| March 31, 2018 | -0.008M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Korsana Biosciences, Inc. | -0.033M |
| PepGen Inc. | -1.155M |
| Q32 Bio, Inc. | 53.39M |
| Bridgebio Oncology Therapeutics, Inc. | -0.763M |
| Oncolytics Biotech, Inc. | -0.048M |